<h2>Union MoS Jitendra Singh Addresses <span class="key-term" data-definition="Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) — A premier Institution of National Importance under the Department of Science & Technology, known for research in medical devices and super‑specialty clinical services (GS1: Institutions, GS3: Health sector).">SCTIMST</span> Convocation 2026</h2>
<p>On <strong>16 May 2026</strong>, <strong>Shri Jitendra Singh</strong>, Union Minister of State (Independent Charge) for Science & Technology and Earth Sciences, virtually addressed the 42nd batch convocation of <span class="key-term" data-definition="Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) — A premier Institution of National Importance under the Department of Science & Technology, known for research in medical devices and super‑specialty clinical services (GS1: Institutions, GS3: Health sector).">SCTIMST</span> in Thiruvananthapuram. The ceremony was presided over by Union Health Secretary <strong>Smt. Punya Salila Srivastava</strong>. The address highlighted the institute’s role in indigenous medical‑device innovation, ongoing health‑policy reforms and the broader vision of a “Viksit Bharat”.</p>
<h3>Key Developments</h3>
<ul>
<li>Approval for hiring ~<strong>800 permanent faculty</strong> will double the institute’s capacity, strengthening its neurosurgery and cardiac science programmes.</li>
<li>Recognition of the <span class="key-term" data-definition="Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) — A government scheme to set up super‑specialty hospitals and AIIMS across India, enhancing tertiary care infrastructure (GS3: Health, GS2: Polity).">PMSSY</span> block and services block as new facilities that will make the institute one of the largest centres for neurosurgery and cardiac care.</li>
<li>Celebration of the institute’s contribution of <strong>7 new medical‑device technologies</strong> transferred to industry this year, underscoring its cost‑effective, indigenous innovation model.</li>
<li>Launch of an eight‑institution MoU cluster to foster interdisciplinary research and accelerate scientific capabilities.</li>
<li>Collaboration with <strong>ISRO</strong> on space‑medicine research, opening avenues for high‑altitude and micro‑gravity health studies.</li>
<li>Secretary Srivastava outlined the continuum of care under <span class="key-term" data-definition="Ayushman Bharat — The flagship health programme comprising Ayushman Arogya Mandirs (primary care) and Pradhan Mantri Jan Arogya Yojana (PM‑JAY) to provide universal health coverage (GS3: Health, GS2: Welfare).">Ayushman Bharat</span>, including the digital health push via the <span class="key-term" data-definition="Ayushman Bharat Digital Mission (ABDM) — Digital health initiative creating ABHA IDs and longitudinal health records to ensure continuity of care (GS3: Digital health, GS4: Ethics).">ABDM</span>.</li>
<li>Regulatory reforms by the <span class="key-term" data-definition="Central Drugs Standard Control Organization (CDSCO) — The national regulatory authority for drugs and medical devices, overseeing approvals and safety (GS3: Health, GS2: Governance).">CDSCO</span> to simplify approval pathways for low‑risk generic drugs and medical devices.</li>
</ul>
<h3>Important Facts</h3>
<p>A total of <strong>130 graduates</strong> received degrees across DM, MCh, MPH, PhD, diploma and post‑doctoral programmes. The institute has treated over <strong>17,000 patients</strong> under the Pradhan Mantri Ayushman Bharat Yojana since 2020. The foundation stone for the <strong>Malini Vasundhara Centre</strong>—a precision, non‑invasive hub for neurological and oncological care—was laid by Prime Minister Narendra Modi.</p>
<h3>UPSC Relevance</h3>
<p>The event touches upon several GS topics: <br/>
• <strong>Health infrastructure development</strong> – PMSSY and AIIMS expansion (GS3). <br/>
• <strong>Universal health coverage</strong> – Ayushman Bharat’s three‑tier referral system and digital health integration (GS3, GS4). <br/>
• <strong>Innovation ecosystem</strong> – Indigenous medical‑device R&D, public‑private partnerships, and space‑medicine collaboration (GS3). <br/>
• <strong>Regulatory reforms</strong> – CDSCO’s simplification measures for generics and devices, relevant to governance and policy (GS2, GS3). <br/>
• <strong>National Health Policy 2017</strong> emphasis on preventive, promotive and palliative care aligns with the Secretary’s remarks on wellness‑focused primary care (GS3).</p>
<h3>Way Forward</h3>
<p>For aspirants, the key take‑aways are:</p>
<ul>
<li>Monitor the rollout of <span class="key-term" data-definition="Ayushman Bharat Digital Mission (ABDM) — Digital health initiative creating ABHA IDs and longitudinal health records to ensure continuity of care (GS3: Digital health, GS4: Ethics).">ABDM</span> and its impact on health‑data governance.</li>
<li>Track the progress of the eight‑institution MoU cluster as a model for interdisciplinary research collaboration.</li>
<li>Observe CDSCO’s regulatory streamlining, especially for low‑risk generics, which could influence future drug‑policy debates.</li>
<li>Assess how the expanded AI‑driven health initiatives (e.g., AI in healthcare strategy with IIT Kanpur) integrate with existing schemes.</li>
<li>Encourage graduates to serve in remote AIIMS and PMSSY super‑specialty blocks, aligning with the government’s push for equitable health access.</li>
</ul>
<p>Overall, the convocation underscores India’s commitment to blending cutting‑edge science with inclusive health policy—a narrative central to UPSC’s health‑sector questions.</p>